Organization · Venture Capital
Propel Bio Partners
Propel Bio Partners is a venture capital firm based in Los Angeles and Seattle, focused on investing in life science companies that advance innovative therapies and technologies. The firm provides financial support and access to a network of medical and operational experts.
Overview
What Propel Bio Partners does
What Propel Bio Partners is
Propel Bio Partners is a venture capital firm based in Los Angeles and Seattle, focused on investing in life science companies that advance innovative therapies and technologies. The firm provides financial support and access to a network of medical and operational experts.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2022
- Approximate age
- About 4 years
- Structured capabilities
- Funder
- Last reviewed
- March 27, 2026
Official channels
Find Propel Bio Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Propel Bio Partners as a funder
Investment thesis
Propel Bio Partners is focused on advancing human health through disruptive therapies and technologies, supporting entrepreneurial life science companies by building ecosystems that help founders achieve their vision.
Focus narrative
The firm invests in life science companies, leveraging its expertise in finance and investment to help advance scientific innovations. Propel Bio Partners is particularly focused on supporting the development of disruptive technologies and therapies that can significantly impact human health.
Value beyond capital
Propel Bio Partners provides its portfolio companies with financial backing as well as access to a robust ecosystem of medical experts, operational advisors, and best-in-class service providers, helping them to achieve their vision and navigate the complexities of the life sciences landscape.
Focus and fit
- Stages
- Seed · Series A · Series B · Growth Equity
- Regions
- Global · North America
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
No specific portfolio companies have been disclosed as the fund is still in its early stages since its launch in 2022.
Common questions
What to know about Propel Bio Partners
Upseed classifies Propel Bio Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.